Search Results For ''

  • Singular Health appoints Kelyniam Global as US-based agent for FDA requirements

    To sell in the US market, every foreign company needs the support of locals. For medtech company Singular Health Group (ASX: SHG), that is Kelyniam Global Inc. The Company has appointed Kelyniam as its US-based agent—a key appointment and integral pre-requisite to satisfy the final FDA regulatory requirement, prior to Singular Health entering the US.

    Read More
    Public
  • Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app

    The Australian fintech space has been rapidly evolving the past few years, where on average most individuals across the country have in excess of 6+ fintech apps downloaded and used regularly on their phone. Amongst the Australians that use fintech services, it has become a standard that they typically invest via apps such as Stake,

    Read More
    Public
  • REA reports decline in listings as property demand slows

    It’s a tough time to be in the real estate sector. With interest rates rising globally and fewer people being able to afford homes, demand is falling, as is overall revenue. For Aussie property tech giant REA Group (ASX: REA), this has meant dealing with declining listings and profits. As per its reports, national residential

    Read More
    Public
  • Skyfii seals the deal with McDonalds to deploy restaurant monitoring technology

    Say no more to cold burgers, wrong orders, and endless waiting times! As customer demand for seamless and efficient service across different platforms is getting higher, omnidata intelligence company Skyfii (ASX: SKF) has signed a three-year agreement with fast-food giant McDonalds. Skyfii will deploy its real-time restaurant monitoring technology and analysis solution to improve customer

    Read More
    Public
  • Artrya to sell its AI healthcare device Salix in the UK following regulatory approval

    As the global rates of heart disease increase, countries are adopting tech solutions for early detection and prevention. That’s where Australian medical technology company Artrya (ASX: AYA) comes in. The Company reported that it had received regulatory approval for its Salix Coronary Anatomy (SCA) product in the United Kingdom.  The European Notified Body (BSI) has

    Read More
    Public
  • ECS affirms that the cannabis is safe amid severe flooding from Loddon River

    In late October 2022, the Loddon River in Victoria reached historic levels, flooding many of Victorian residents’ homes. Along with that, the floods also nearly engulfed the ECS  Botanics Holdings (ASX: ECS) medicinal cannabis production and processing facility  located there.  The floods affected everyday work at the ECS facility as significant road closures and flooding

    Read More
    Public